futurehealth.com tirzepatide FDA Grants a New Indication for Obesity Management FuturHealth Tirzepatide: Clinical Considerations &

By week 12, you should have a clear picture of whether the switch is working

After first use Keep the pen injector with Sejaro that is in use or carried as a spare one at a temperature below 30 C for not more than 30 days

The medication is administered once weekly via subcutaneous injection, with doses ranging from 2.5 mg to 15 mg

Medication-related side effects are primarily gastrointestinal and are most pronounced during the early weeks of treatment and after each dose increase

Storage requirements Before reconstitution, lyophilized HCG can be stored at room temperature, though refrigeration extends its shelf life